medical research groups

3V Medical Research Group is a private biotechnology company based in Pittsburgh, Pennsylvania, dedicated to developing innovative treatments for high-prevalence conditions using simple molecules and advanced drug delivery systems. The company's lead candidate, Luxsol (3VM1000), is a patented nebulized copper-based suspension designed for the prevention and treatment of respiratory infections such as COVID-19 and influenza. Additionally, the company is developing Ostrolux, a topical analgesic cream targeting chronic pain from osteoarthritis and radiation dermatitis, with a mechanism of action involving opiate receptor binding. 3V Medical Research Group focuses on providing effective therapies with improved safety profiles compared to existing treatments, such as oral NSAIDs. The company's proprietary technology leverages low-concentration copper formulations to achieve therapeutic efficacy without associated toxicity.